Malignant Breast Neoplasm — Trials

Malignant Breast Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,627
Recruiting: 1,400
Ph III recruiting: 154
Growth YoY: +20.8%
Industry share: 18%
Top sponsor: Fudan University
Termination share: 25.6%
Trials / 1,000 deaths: 61.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,368)

clinicaltrialsPublishedShowing 301–350 of 498 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06926920	A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer	recruiting	Phase 1 / Phase 2	100	Gilead SciencesINDUSTRY	3	Jan 30, 2026	clinicaltrials
NCT04680715	Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer(RPOS+2)	recruiting	Phase 2	40	Centre Antoine LacassagneOTHER	1	Jan 29, 2026	clinicaltrials